MRC1 and pneumonia: siRNA knockdown of MRC‐1 or treatment with an anti‐MRC‐1 antibody increased the TNF response to Ply‐expressing S. pneumoniae from DCs and ex vivo alveolar macrophages, as well as in a mouse model of pneumonia [22].